Transthoracic Ultrasonography Findings and Their Relation to Spirometric Indices in Patients With Obstructive and Restrictive Respiratory Diseases

Sponsor
Sohag University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05175313
Collaborator
Cairo University (Other)
100
1
5
19.9

Study Details

Study Description

Brief Summary

Evaluation of respiratory function is considered a crucial component in the assessment of patients with a wide range of respiratory diseases. Spirometry is considered a common method of measuring pulmonary function. Recently, Transthoracic ultrasound yields important diagnostic information within minutes. Respiratory muscle ultrasound is used to evaluate the anatomy and function of the respiratory system.

Condition or Disease Intervention/Treatment Phase
  • Radiation: transthoracic ultrasonography
  • Device: spirometry

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Transthoracic Ultrasonography Findings and Their Relation to Spirometric Indices in Patients With Obstructive and Restrictive Respiratory Diseases
Actual Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
normal people

people who don't complain of respiratory diseases will be examined by chest ultrasound and pulmonary function test.

Radiation: transthoracic ultrasonography
lung ultrasonography Diaphragm and respiratory muscle ultrasound inferior vena cava ultrasound

Device: spirometry
pulmonary function test : FVC, FEV1, FEV1/FVC will be measured.

obstructive respiratory diseases

the patients who are diagnosed with either COPD or asthma.

Radiation: transthoracic ultrasonography
lung ultrasonography Diaphragm and respiratory muscle ultrasound inferior vena cava ultrasound

Device: spirometry
pulmonary function test : FVC, FEV1, FEV1/FVC will be measured.

restrictive respiratory diseases

patient with either ILD

Radiation: transthoracic ultrasonography
lung ultrasonography Diaphragm and respiratory muscle ultrasound inferior vena cava ultrasound

Device: spirometry
pulmonary function test : FVC, FEV1, FEV1/FVC will be measured.

Outcome Measures

Primary Outcome Measures

  1. investigate the correlation between transthoracic ultrasonography findings and their relation to spirometric indices in patients with different respiratory diseases. [6months]

    we will study the degree of change in lung ultrasound, diaphragm, and respiratory muscles ultrasound, inferior vena cava ultrasound in obstructive and restrictive respiratory diseases .also, we find their correlation with spirometric indices in these diseases.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

1 -age >18 years 2-patients diagnosed with COPD or asthma. 3-patients diagnosed with ILD or any other restrictive lung diseases. 4-normal people.

Exclusion Criteria:
  1. age <18 years old.

  2. critically ill patients in intensive care units.

  3. patients with neurological diseases.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sohag university hospital Sohag Egypt

Sponsors and Collaborators

  • Sohag University
  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Esraa Faragallah Abdelaal, assistant lecturer, Sohag University
ClinicalTrials.gov Identifier:
NCT05175313
Other Study ID Numbers:
  • Soh-Med-21-12-15
First Posted:
Jan 3, 2022
Last Update Posted:
Aug 2, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 2, 2022